ABSTRACT
Neuroergonomics is an emerging field that investigates the human brain about behavioral performance in natural environments and everyday settings. This study investigated the body and brain activity correlates of a typical daily activity, hot beverage preparation, and consumption in a realistic office environment where participants performed natural daily tasks. Using wearable, battery operated and wireless Electroencephalogram (EEG) and Electrodermal activity (EDA) sensors, neural and physiological responses were measured in untethered, freely moving participants who prepared hot beverages using two different machines (a market leader and follower as determined by annual US sales). They later consumed the drinks they had prepared in three blocks. Emotional valence was estimated using frontal asymmetry in EEG alpha band power and emotional arousal was estimated from EDA tonic and phasic activity. Results from 26 participants showed that the market-leading coffee machine was more efficient to use based on self-reports, behavioral performance measures, and there were significant within-subject differences in valence between the two machine use. Moreover, the market leader user interface led to greater self-reported product preference, which was further supported by significant differences in measured arousal and valence (EDA and EEG, respectively) during coffee production and consumption. This is the first study that uses a multimodal and comprehensive assessment of coffee machine use and beverage consumption in a naturalistic work environment. Approaches described in this study can be adapted in the future to other task-specific machine usability and consumer neuroscience studies.
ABSTRACT
BACKGROUND: A survey of Western Australia's general practitioners' (GPs') knowledge and practices relating to genital chlamydia infection was conducted in mid-2005, prior to a multi-media campaign which encouraged 15-24 year olds to seek chlamydia testing through their general practitioner (GP). The survey aimed to raise GPs' awareness of chlamydia in preparation for the campaign and to establish a baseline measure of their chlamydia-related knowledge and practices. METHODS: All 2038 GPs registered on the Australian Medical Publishing Company's database as practising in Western Australia were sent a survey which covered clinical features of chlamydia, investigations, treatment and public health issues; 576 (29%) responded. RESULTS: Most GPs were aware of chlamydia being common in the 20-24 year old age group, but less than half were aware that it is common in 15-19 year olds. GPs missed many opportunities for chlamydia testing in patients likely to be at risk of STIs, largely because they thought the patient would be embarrassed. It is of concern that public health responsibilities in relation to chlamydia, ie notification and contact tracing, were not undertaken by all GPs. CONCLUSION: Australia is currently piloting chlamydia screening. For this to be successful, GPs will need to maintain current knowledge and clinical suspicion about chlamydia, and be comfortable in asking and receiving information about sexual behaviours. Only then will GPs have a significant impact on curbing Australia's ever-increasing rates of chlamydia.
